Tenax TherapeuticsTENX
13F holders, Q1 2024 (March 31)9holders
$4.22avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Tenax Therapeutics Inc. (TENX) in their 13F filings. The largest holders were Qube Research & Technologies Ltd ($19K), UBS Group AG ($6K) and Tower Research Capital LLC (TRC) ($2K).
- Company
- Tenax Therapeutics Inc.
- CUSIP
- 88032L605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $31K |
| Exits | 0 | $0 |
Ownership 9 holders
| Qube Research & Technologies Ltd | 0.00% | New | 4,407 | $19K |
| UBS Group AG | 0.00% | New | 1,384 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 537 | $2K |
| CIBC Private Wealth Group LLC | 0.00% | New | 343 | $1K |
| BlackRock Inc. | 0.00% | New | 300 | $1K |
| Morgan Stanley | 0.00% | New | 260 | $1K |
| Wells Fargo & Company | 0.00% | New | 2 | $8 |
| Allworth Financial LP | 0.00% | New | 1 | $5 |
| Tucker Asset Management LLC | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is TENX's weight in each manager's 13F, not the share of Tenax Therapeutics Inc. the manager owns.